Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet

被引:104
作者
Maagaard, Louise [1 ]
Ankersen, Dorit V. [1 ]
Vegh, Zsuzsanna [2 ]
Burisch, Johan [3 ]
Jensen, Lisbeth [4 ]
Pedersen, Natalia [5 ]
Munkholm, Pia [1 ]
机构
[1] North Zealand Univ Hosp, Dept Gastroenterol, Frederikssundsvej 30, DK-3600 Frederikssund, Denmark
[2] Semmelweis Univ, Dept Med 1, H-1083 Budapest, Hungary
[3] Hvidovre Univ Hosp, Dept Gastroenterol, DK-2650 Hvidovre, Denmark
[4] Herlev Univ Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark
[5] Slagelse Univ Hosp, Dept Gastroenterol, DK-4200 Slagelse, Denmark
关键词
Low FODMAP; Irritable bowel syndrome; Inflammatory bowel disease; Adherence; Disease course; QUALITY-OF-LIFE; CLINICAL-ASSESSMENT; DISEASE-ACTIVITY; CROHNS-DISEASE; EPIDEMIOLOGY; INFLAMMATION; PREVALENCE; MANAGEMENT; IMPROVES; IMPACT;
D O I
10.3748/wjg.v22.i15.4009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate patient-reported outcomes from, and adherence to, a low FODMAP diet among patients suffering from irritable bowel syndrome and inflammatory bowel disease. METHODS: Consecutive patients with irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD) and co-existing IBS fulfilling the ROME. criteria, who previously attended an outpatient clinic for low FODMAP diet (LFD) dietary management and assessment by a gastroenterologist, were invited to participate in a retrospective questionnaire analysis. The questionnaires were sent and returned by regular mail and gathered information on recall of dietary treatment, efficacy, symptoms, adherence, satisfaction, change in disease course and stool type, and quality of life. Before study enrolment all patients had to sign an informed written consent. RESULTS: One hundred and eighty patients were included, 131 (73%) IBS and 49 (27%) IBD patients. Median age was 43 years (range: 18-85) and 147 (82%) were females. Median follow-up time was 16 mo (range: 2-80). Eighty-six percent reported either partial (54%) or full (32%) efficacy with greatest improvement of bloating (82%) and abdominal pain (71%). The proportion of patients with full efficacy tended to be greater in the IBD group than in the IBS group (42% vs 29%, p = 0.08). There was a significant reduction in patients with a chronic continuous disease course in both the IBS group (25%, p < 0.001) and IBD group (23%, p = 0.002) along with a significant increase in patients with a mild indolent disease course of 37% (p < 0.001) and 23% (p = 0.002), respectively. The proportion of patients having normal stools increased with 41% in the IBS group (p < 0.001) and 66% in the IBD group (p < 0.001). One-third of patients adhered to the diet and high adherence was associated with longer duration of dietary course (p < 0.001). Satisfaction with dietary management was seen in 83 (70%) IBS patients and 24 (55%) IBD patients. Eighty-four percent of patients lived on a modified LFD, where some foods rich in FODMAPs were reintroduced, and 16% followed the LFD by the book without deviations. Wheat, dairy products, and onions were the foods most often not reintroduced by patients. CONCLUSION: These data suggest that a diet low in FODMAPs is an efficacious treatment solution in the management of functional bowel symptoms for IBS and IBD patients.
引用
收藏
页码:4009 / 4019
页数:11
相关论文
共 32 条
[1]   Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon [J].
Barrett, J. S. ;
Gearry, R. B. ;
Muir, J. G. ;
Irving, P. M. ;
Rose, R. ;
Rosella, O. ;
Haines, M. L. ;
Shepherd, S. J. ;
Gibson, P. R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (08) :874-882
[2]   Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity [J].
Berrill, J. W. ;
Green, J. T. ;
Hood, K. ;
Campbell, A. K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (01) :44-51
[3]   Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease - An ECCO-EpiCom study [J].
Burisch, J. ;
Weimers, P. ;
Pedersen, N. ;
Cukovic-Cavka, S. ;
Vucelic, B. ;
Kaimakliotis, I. ;
Duricova, D. ;
Bortlik, M. ;
Shonova, O. ;
Vind, I. ;
Avnstrom, S. ;
Thorsgaard, N. ;
Krabbe, S. ;
Andersen, V. ;
Dahlerup, J. F. ;
Kjeldsen, J. ;
Salupere, R. ;
Olsen, J. ;
Nielsen, K. R. ;
Manninen, P. ;
Collin, P. ;
Katsanos, K. H. ;
Tsianos, E. V. ;
Ladefoged, K. ;
Lakatos, L. ;
Ragnarsson, G. ;
Bjornsson, E. ;
Bailey, Y. ;
O'Morain, C. ;
Schwartz, D. ;
Odes, S. ;
Valpiani, D. ;
Boni, M. C. ;
Jonaitis, L. ;
Kupcinskas, L. ;
Turcan, S. ;
Barros, L. ;
Magro, F. ;
Lazar, D. ;
Goldis, A. ;
Nikulina, I. ;
Belousova, E. ;
Fernandez, A. ;
Sanroman, L. ;
Almer, S. ;
Zhulina, Y. ;
Halfvarson, J. ;
Arebi, N. ;
Diggory, T. ;
Sebastian, S. .
JOURNAL OF CROHNS & COLITIS, 2014, 8 (09) :1030-1042
[4]   Secondary prevention of coronary heart disease: Patient beliefs and health-related behaviour [J].
Byrne, M ;
Walsh, J ;
Murphy, AW .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2005, 58 (05) :403-415
[5]   Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome [J].
Camilleri, Michael ;
Lasch, Karen ;
Zhou, Wen .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 303 (07) :G775-G785
[6]   The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study [J].
de Roest, R. H. ;
Dobbs, B. R. ;
Chapman, B. A. ;
Batman, B. ;
O'Brien, L. A. ;
Leeper, J. A. ;
Hebblethwaite, C. R. ;
Gearry, R. B. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (09) :895-903
[7]   Development of a Web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment [J].
Elkjaer, Margarita ;
Burisch, Johan ;
Avnstrom, Soren ;
Lynge, Elsebeth ;
Munkholm, Pia .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (06) :695-704
[8]   The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress [J].
Francis, CY ;
Morris, J ;
Whorwell, PJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (02) :395-402
[9]   Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study [J].
Gearry, Richard B. ;
Irving, Peter M. ;
Barrett, Jacqueline S. ;
Nathan, Debbie M. ;
Shepherd, Sue J. ;
Gibson, Peter R. .
JOURNAL OF CROHNS & COLITIS, 2009, 3 (01) :8-14
[10]   Food Choice as a Key Management Strategy for Functional Gastrointestinal Symptoms [J].
Gibson, Peter R. ;
Shepherd, Susan J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (05) :657-666